- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapse of Hematological Malignancies
Total 2278 results
-
Janssen Research & Development, LLCCompletedHematologic MalignanciesUnited States
-
Hutchison Medipharma LimitedIqvia Pty LtdUnknownHematologic MalignanciesAustralia
-
University of Illinois at ChicagoTerminatedHematologic MalignanciesUnited States
-
Loyola UniversityGamida Cell ltdCompleted
-
Duke UniversityCompletedA Controlled Study of Stem Cell Transplantation Medical Home Care Compared to Standard Hospital CareHematologic MalignanciesUnited States
-
Institut Paoli-CalmettesInnate PharmaUnknownHematologic MalignanciesFrance
-
St. Jude Children's Research HospitalGenzyme, a Sanofi CompanyCompleted
-
Dana-Farber Cancer InstituteMiltenyi Biomedicine GmbHCompletedHematologic MalignanciesUnited States
-
Instituto de Investigacion Sanitaria La FeUnknown
-
Indiana University School of MedicineGenzyme, a Sanofi CompanyCompletedHematologic MalignanciesUnited States
-
Emory UniversityCompletedHematologic Diseases | Hematologic MalignanciesUnited States
-
Emory UniversityCompleted
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; AmgenCompletedHematologic MalignanciesUnited States
-
Assistance Publique - Hôpitaux de ParisPierre and Marie Curie University; Université Paris XIICompletedHematologic Neoplasms | RelapseFrance
-
Brigham and Women's HospitalDana-Farber Cancer Institute; Robert Wood Johnson Foundation; American Society...RecruitingHematologic MalignancyUnited States
-
Peking University People's HospitalRecruiting
-
Prolacta BioscienceRecruiting
-
Dana-Farber Cancer InstituteRecruiting
-
Northside Hospital, Inc.RecruitingHematologic MalignancyUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingHematologic Malignancy
-
St. Petersburg State Pavlov Medical UniversityActive, not recruitingHematologic MalignancyRussian Federation
-
Exact Sciences CorporationTerminatedHematologic MalignancyUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematologic MalignancyUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Withdrawn
-
Monash UniversityRecruitingHypogammaglobulinemia | Haematological MalignancyAustralia
-
Foghorn Therapeutics Inc.RecruitingRefractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Relapsed Acute Myeloid Leukemia | Relapsed Myelodysplastic Syndromes | Refractory Myelodysplastic Syndromes | Advanced Hematologic Malignancy | Relapsed Chronic Myelomonocytic LeukemiaUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownCancer | Septic Shock | AnemiaFrance
-
University of LiegeUniversity Hospital, Gasthuisberg; University Hospital, Ghent; University Hospital... and other collaboratorsActive, not recruitingHematological Malignancies | Graft-Versus-Host DiseaseBelgium
-
He HuangCompletedHematologic MalignanciesChina
-
SecuraBioTerminatedHematologic MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedHematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterChiron CorporationCompletedHematologic MalignanciesUnited States
-
Fate TherapeuticsTerminatedA Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic MalignanciesHematologic MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedHematologic MalignanciesUnited States
-
Anne Beaven, MDNovartisWithdrawnHematologic MalignanciesUnited States
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); The Ottawa Hospital; Hamilton... and other collaboratorsCompletedHematologic MalignanciesCanada
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHematologic MalignanciesUnited States
-
Infinity Pharmaceuticals, Inc.Terminated
-
University Hospital TuebingenCompletedHematologic MalignanciesGermany
-
Genzyme, a Sanofi CompanyTerminatedHematologic MalignanciesUnited States
-
Emory UniversityCompletedHematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Kah Poh LohWithdrawn
-
Kiromic, Inc.WithdrawnCancer | Hematologic MalignanciesUnited States
-
GlaxoSmithKlineWithdrawn
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingHematologic MalignancyChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Massachusetts General HospitalRecruiting
-
Center for International Blood and Marrow Transplant...National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedHematologic MalignancyUnited States
-
Rigshospitalet, DenmarkNovo Nordisk A/SCompletedHematologic MalignancyDenmark